Arbutus Biopharma (ABUS) Change in Taxes (2013 - 2019)
Arbutus Biopharma's (ABUS) quarterly Change in Taxes came in at -$98000.0 in Q1 2019, down 5000.0% year-on-year from $2000.0 in Q1 2018, and down 300.0% quarter-over-quarter from $49000.0 in Q4 2018.
Arbutus Biopharma (ABUS) Change in Taxes (2013 - 2019) Analysis & Trends
Arbutus Biopharma has disclosed Change in Taxes across 6 years of filings, most recently posting -$98000.0 for Q1 2019.
- Change in Taxes for Q1 2019 came in at -$98000.0, down 5000.0% year-over-year; the trailing twelve-month figure through Mar 2019 was -$49000.0 (down 131.21% YoY), and the FY2018 annual result was $49000.0, up 4.26% from the prior year.
- Change in Taxes came in at -$98000.0 for Q1 2019 at Arbutus Biopharma, down from $49000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $145000.0 in Q4 2016 to a low of -$98000.0 in Q2 2016.
- The 4-year median for Change in Taxes is $15000.0 (2017), against an average of $18888.9.
- Across the five-year window, Change in Taxes jumped 210.2% in 2017 and tumbled 5000.0% in 2019, its largest moves.
- Arbutus Biopharma's Change in Taxes stood at $145000.0 in 2016, then slumped by 142.07% to -$61000.0 in 2017, then surged by 180.33% to $49000.0 in 2018, then slumped by 300.0% to -$98000.0 in 2019.
- The last three Change in Taxes figures came in at -$98000.0 (Q1 2019), $49000.0 (Q4 2018), and $2000.0 (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -98,000.00 |
| Mar 31, 2019 | -98,000.00 |
| Dec 31, 2018 | 49,000.00 |
| Dec 31, 2018 | 49,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Dec 31, 2017 | -61,000.00 |
| Dec 31, 2017 | -61,000.00 |
| Sep 30, 2017 | 108,000.00 |
| Sep 30, 2017 | 108,000.00 |
| Jun 30, 2017 | 108,000.00 |
| Jun 30, 2017 | 108,000.00 |
| Mar 31, 2017 | 15,000.00 |
| Mar 31, 2017 | 15,000.00 |
| Dec 31, 2016 | 145,000.00 |
| Dec 31, 2016 | 145,000.00 |
| Jun 30, 2016 | -98,000.00 |
| Jun 30, 2016 | -98,000.00 |
| Dec 31, 2014 | 52,000.00 |
| Dec 31, 2014 | 52,000.00 |